Myelofibrosis A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of INCB050465 and ruxolitinib in subjects with myelofibrosis Talk to your doctor if you are interested in participating […]
Geron announces removal of Full Clinical Hold on Imetelstat The full clinical hold on Geron’s sole pipeline candidate, investigation new drug (IND), Imetelstat, has been lifted by the FDA. The company does not intend to conduct further studies or develop imetelstat for the treatment of essential thrombocythemia (ET) or polycythemia vera (PV). The development plan […]
Geron Corp announced today that the partial clinical hold on clinical trials of imetelstat in myelofibrosis has been removed by the FDA. The hold for essential thrombocythemia and polycythemia vera remains. Click here for the full story.
Find a MPN Specialist in the United States - Doctor … Reviewed
Patient Assistance Programs, Medications for MPN Patients by David … [Read More...]
Part 1 in a Series - "Mast Cell Mania" at the Root of many … [Read More...]
by David Wallace Fedratinib by Celgene, offered on Expanded Access Program … [Read More...]
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) - … [Read More...]
MPN Chronicles Podcast - 04, PV … [Read More...]
MPN News
Follow Us!